COMMUNIQUÉS West-GlobeNewswire
-
Philips presents study results at Heart Rhythm Annual Meeting demonstrating benefits of its AI-powered cardiac monitoring solutions
17/05/2024 - 10:00 -
Notification of managers’ transactions
17/05/2024 - 11:10 -
Trading by management and close relations of management
17/05/2024 - 12:39 -
QuTEM Receives GMP Certificates and Manufacturing Permits for Transmission Electron Microscopy Laboratory from the Swedish Medical Products Agency
17/05/2024 - 08:00 -
HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematological Malignancy Programs Data to be Presented at the upcoming EHA2024 Congress
17/05/2024 - 02:00 -
Erasca Announces Pricing of Underwritten Offering of Common Stock
17/05/2024 - 02:00 -
Erasca Announces Strategic In-Licensing of RAS-Targeting Franchise
17/05/2024 - 02:02 -
Inventiva annonce la recommandation positive du quatrième DMC de l’étude clinique NATiV3 Phase III avec lanifibranor dans la MASH/NASH
16/05/2024 - 22:00 -
Inventiva announces the positive recommendation of the fourth DMC of the NATiV3 Phase III clinical trial with lanifibranor in patients with MASH/NASH
16/05/2024 - 22:00 -
Galapagos creates new subscription right plans
16/05/2024 - 22:01 -
Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) Conference
16/05/2024 - 22:02 -
ArriVent Appoints John Hohneker, M.D., to its Board of Directors
16/05/2024 - 22:05 -
Merit Medical Shareholders Elect Silvia M. Perez as New Director
16/05/2024 - 22:05 -
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
16/05/2024 - 22:05 -
Option Care Health to Participate in Upcoming Investor Conferences
16/05/2024 - 22:05 -
Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
16/05/2024 - 22:05 -
New Study Published in JCO Precision Oncology Shows Myriad Genetics' Prolaris Test Can Predict Benefit of Hormone Therapy Treatment in Men with Localized Prostate Cancer
16/05/2024 - 22:05 -
Spero Therapeutics to Participate in H.C. Wainwright Annual BioConnect Investor Conference
16/05/2024 - 22:05 -
Ventyx Biosciences to Participate in Three Upcoming Investor Conferences
16/05/2024 - 22:05
Pages